Cargando…
Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled receptor and can be activated by somatostatin or its synthetic analogs. SSTR2 is therefore extensively studied as a marker and target for the diagnosis and treatment of meningioma. Accumulating studies have reveal...
Autores principales: | Wu, Wei, Zhou, Yunxiang, Wang, Yali, Liu, Lihong, Lou, Jianyao, Deng, Yongchuan, Zhao, Peng, Shao, Anwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494964/ https://www.ncbi.nlm.nih.gov/pubmed/33014821 http://dx.doi.org/10.3389/fonc.2020.01633 |
Ejemplares similares
-
mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015) -
Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
por: Lou, Jianyao, et al.
Publicado: (2021) -
Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Yu, Benxia, et al.
Publicado: (2017) -
Retracted: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and
Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma
(TSHoma)
por: Song, Hao, et al.
Publicado: (2018) -
Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
por: Harda, Kristof, et al.
Publicado: (2020)